Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-24

FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for REYATAZ (atazanavir), indicating a modification to the approved labeling. The submission was filed by E.R. Squibb & …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REYATAZ (atazanavir)

Snippet

SUPPL AP for REYATAZ (ATAZANAVIR)